Arcellx, Inc.
General ticker "ACLX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.3B (TTM average)
Arcellx, Inc. follows the US Stock Market performance with the rate: 19.5%.
Estimated limits based on current volatility of 0.0%: low 115.02$, high 115.10$
Factors to consider:
- Earnings expected soon, date: 2026-05-07 bmo
- Total employees count: 163 (+25.4%) as of 2024
- Top business risk factors: Limited operating history, Third-party risks, Insufficient funding, Regulatory and compliance, Geopolitical risks
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [43.38$, 86.04$]
- 2026-12-31 to 2027-12-31 estimated range: [37.63$, 76.72$]
Financial Metrics affecting the ACLX estimates:
- Negative: with PPE of -15.9 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -5.75 <= 0.07
- Positive: Investing cash flow per share per price, % of 2.36 > -0.65
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
- Negative: Industry earnings per price (median), % of -14.62 <= 0
- Negative: negative Industry operating income (median)
- Negative: negative Net income
Short-term ACLX quotes
Long-term ACLX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $110.32MM | $107.94MM | $22.29MM |
| Operating Expenses | $200.20MM | $245.51MM | $275.37MM |
| Operating Income | $-89.88MM | $-137.57MM | $-253.08MM |
| Non-Operating Income | $19.85MM | $32.29MM | $24.22MM |
| R&D Expense | $133.85MM | $157.09MM | $157.61MM |
| Income(Loss) | $-70.03MM | $-105.28MM | $-228.87MM |
| Taxes | $0.66MM | $2.07MM | $0.07MM |
| Profit(Loss)* | $-70.69MM | $-107.35MM | $-228.93MM |
| Stockholders Equity | $485.38MM | $454.79MM | $402.35MM |
| Assets | $825.13MM | $711.33MM | $603.99MM |
| Operating Cash Flow | $207.57MM | $-83.47MM | $-210.26MM |
| Capital expenditure | $21.43MM | $13.43MM | $2.33MM |
| Investing Cash Flow | $-154.51MM | $-183.04MM | $86.30MM |
| Financing Cash Flow | $279.16MM | $-24.09MM | $98.53MM |
| Earnings Per Share** | $-1.47 | $-2.00 | $-4.07 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.